Scientists develop first drug-like compounds to inhibit elusive cancer-linked enzymes
Structural biology techniques helped researchers target the nuclear receptor-binding SET domain family for the first time; its malfunction is associated with several types of cancer.
Read Original Article: Scientists develop first drug-like compounds to inhibit elusive cancer-linked enzymes »
